These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8868112)

  • 1. Synthesis and biological evaluation of proline derivatives as potential angiotensin converting enzyme inhibitor.
    Giugliano G; Grieco P; Ialenti A; Mottola M; Perissutti E; Santagada V
    Boll Soc Ital Biol Sper; 1996; 72(1-2):29-36. PubMed ID: 8868112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 2-substituted-N-carboxymethyl-1,5-benzothiazepin-4-ones and -1,4-benzothiazin-3-ones and their evaluation as angiotensin converting enzyme inhibitors.
    Trapani G; Latrofa A; Franco M; Liso G
    Farmaco; 1995 Feb; 50(2):107-12. PubMed ID: 7766274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship study between Ornithyl-Proline and Lysyl-Proline based tripeptidomimics as angiotensin-converting enzyme inhibitors.
    Pavar MC; Hanif K; Azam A; Lata S; Qadar Pasha MA; Pasha S
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2117-21. PubMed ID: 16464585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling.
    Redelinghuys P; Nchinda AT; Chibale K; Sturrock ED
    Biol Chem; 2006 Apr; 387(4):461-6. PubMed ID: 16606345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.
    Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V
    Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of angiotensin converting enzyme by L-alanyl-4 or 5-substituted-L-prolines and their N alpha-phosphoryl-derivatives.
    Alexandrou EN; Liakopoulou-Kyriakides M
    Biochem Int; 1990; 21(2):271-8. PubMed ID: 2403366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and enzyme inhibitory activities of new trifluoromethyl-containing inhibitors for angiotensin converting enzyme.
    Ojima I; Jameison FA; Pete B; Radunz H; Schittenhelm C; Lindner HJ; Emith AE
    Drug Des Discov; 1994 Feb; 11(2):91-113. PubMed ID: 8075303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors.
    Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4612-5. PubMed ID: 16784850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthesis and angiotensin converting enzyme (ACE) inhibitory activity of chalcones and their pyrazole derivatives.
    Bonesi M; Loizzo MR; Statti GA; Michel S; Tillequin F; Menichini F
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1990-3. PubMed ID: 20167484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE inhibitors hypothesis generation for selective design, synthesis and biological evaluation of 3-mercapto-2-methyl-propanoyl-pyrrolidine-3-imine derivatives as antihypertensive agents.
    Ismail MA; Nabil Aboul-Enein M; Abouzid KA; Abou El Ella DA; Ismail NS
    Bioorg Med Chem; 2009 May; 17(10):3739-46. PubMed ID: 19403313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function studies of BPP-BrachyNH
    Arcanjo DDR; Vasconcelos AG; Nascimento LA; Mafud AC; Plácido A; Alves MMM; Delerue-Matos C; Bemquerer MP; Vale N; Gomes P; Oliveira EB; Lima FCA; Mascarenhas YP; Carvalho FAA; Simonsen U; Ramos RM; Leite JRSA
    Eur J Med Chem; 2017 Oct; 139():401-411. PubMed ID: 28810191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the importance of spacial and conformational domains in captopril analogs for angiotensin converting enzyme activity.
    Hanessian S; Reinhold U; Saulnier M; Claridge S
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2123-8. PubMed ID: 9873498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibition.
    Ottaviani JI; Actis-Goretta L; Villordo JJ; Fraga CG
    Biochimie; 2006; 88(3-4):359-65. PubMed ID: 16330143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors: N-(mercaptoacyl)-4-substituted-(S)-prolines.
    Smith EM; Swiss GF; Neustadt BR; Gold EH; Sommer JA; Brown AD; Chiu PJ; Moran R; Sybertz EJ; Baum T
    J Med Chem; 1988 Apr; 31(4):875-85. PubMed ID: 2832605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between metabolism and pharmacologic activity of SQ 27,786, an angiotensin converting enzyme inhibitor with potent diuretic activity.
    Everett DW; Singhvi SM; DeForrest JM; Morrison RA; Weinstein SH; Migdalof BH
    Drug Des Deliv; 1987 Sep; 2(1):23-34. PubMed ID: 3509342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2.
    Mores A; Matziari M; Beau F; Cuniasse P; Yiotakis A; Dive V
    J Med Chem; 2008 Apr; 51(7):2216-26. PubMed ID: 18324760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of novel 2-butyl-4-chloro-1-methylimidazole embedded chalcones and pyrazoles as angiotensin converting enzyme (ACE) inhibitors.
    Kantevari S; Addla D; Bagul PK; Sridhar B; Banerjee SK
    Bioorg Med Chem; 2011 Aug; 19(16):4772-81. PubMed ID: 21782455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibitors as antihypertensive agents: 1-[(2-mercaptocycloalkyl)carbonyl]-L-prolines.
    Ciabatti R; Padova G; Bellasio E; Tarzia G; Depaoli A; Battaglia F; Cellentani M; Barone D; Baldoli E
    J Med Chem; 1986 Mar; 29(3):411-7. PubMed ID: 3005576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the furanacryloyl-L-phenylalanylglycylglycine assay for determination of angiotensin-I-converting enzyme inhibitory activity.
    Murray BA; Walsh DJ; FitzGerald RJ
    J Biochem Biophys Methods; 2004 May; 59(2):127-37. PubMed ID: 15163524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.